These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 31761238
1. How biomimetic amino modified mesoporous silica xerogel regulates loading and in vitro sustained delivery of levorotary ofloxacin. Zhang P, Lu T, Xia X, Wu L, Shao L, Zhou J, Li J. Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110266. PubMed ID: 31761238 [Abstract] [Full Text] [Related]
2. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification. Li J, Xu L, Wang H, Yang B, Liu H, Pan W, Li S. Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425 [Abstract] [Full Text] [Related]
3. Molecular imprinting functionalized silica xerogel for selective recognition of levorotatory ofloxacin. Li J, Li S, He Z. Mater Sci Eng C Mater Biol Appl; 2017 Feb 01; 71():999-1003. PubMed ID: 27987799 [Abstract] [Full Text] [Related]
4. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug. Li J, Xu L, Yang B, Wang H, Bao Z, Pan W, Li S. Int J Pharm; 2015 Aug 15; 492(1-2):191-8. PubMed ID: 26163764 [Abstract] [Full Text] [Related]
5. Evaluation of biomimetically synthesized mesoporous silica nanoparticles as drug carriers: Structure, wettability, degradation, biocompatibility and brain distribution. Li H, Wu X, Yang B, Li J, Xu L, Liu H, Li S, Xu J, Yang M, Wei M. Mater Sci Eng C Mater Biol Appl; 2019 Jan 01; 94():453-464. PubMed ID: 30423730 [Abstract] [Full Text] [Related]
10. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin. Li J, Guo Y, Li H, Shang L, Li S. Artif Cells Nanomed Biotechnol; 2018 Aug 01; 46(5):1085-1094. PubMed ID: 28776393 [Abstract] [Full Text] [Related]
12. Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility. Hu B, Wang J, Li J, Li S, Li H. Int J Nanomedicine; 2020 Aug 01; 15():601-618. PubMed ID: 32099354 [Abstract] [Full Text] [Related]
13. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release. Geng H, Zhao Y, Liu J, Cui Y, Wang Y, Zhao Q, Wang S. Int J Pharm; 2016 Aug 20; 510(1):184-94. PubMed ID: 27262268 [Abstract] [Full Text] [Related]
16. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores. Han J, Sun J, Bai S, Panezai H, Jin X, Wu X. J Pharm Sci; 2015 Dec 20; 104(12):4299-4306. PubMed ID: 26501935 [Abstract] [Full Text] [Related]
17. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine. Li H, Li H, Wei C, Ke J, Li J, Xu L, Liu H, YangYang, Li S, Yang M. Eur J Pharm Sci; 2018 May 30; 117():321-330. PubMed ID: 29530545 [Abstract] [Full Text] [Related]
18. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides. Braun K, Pochert A, Lindén M, Davoudi M, Schmidtchen A, Nordström R, Malmsten M. J Colloid Interface Sci; 2016 Aug 01; 475():161-170. PubMed ID: 27174622 [Abstract] [Full Text] [Related]
19. Gel-Mediated Electrospray Assembly of Silica Supraparticles for Sustained Drug Delivery. Ma Y, Björnmalm M, Wise AK, Cortez-Jugo C, Revalor E, Ju Y, Feeney OM, Richardson RT, Hanssen E, Shepherd RK, Porter CJH, Caruso F. ACS Appl Mater Interfaces; 2018 Sep 19; 10(37):31019-31031. PubMed ID: 30192499 [Abstract] [Full Text] [Related]